Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Key Gene in Deadly Head and Neck Cancer Identified

June 19, 2015 8:45 am | by Monash University | News | Comments

Researchers have made the first real breakthrough in 50 years in understanding how cancers of the head and neck develop. Read more...


Blood Protein May Indicate Risk of Alzheimer's Disease

June 19, 2015 8:40 am | by King's College London | News | Comments

The new research used data from over 100 sets of identical twins from Twins UK, the biggest adult twin cohort in the UK. Read more...


Scientists Identify Protein that Sustain Heart Function into Old Age

June 18, 2015 11:59 am | by Johns Hopkins University | News | Comments

The human heart makes precious few new cells but manages to generate billions of life-sustaining beats as it grows old. Read more...


Research Team Issued Patent for New Anesthesia Monitoring Technology

June 18, 2015 11:45 am | by Wayne State University | News | Comments

While anesthesia has gotten much safer over the years, there is still a need for improved health monitoring systems during surgery. Read more...


Eli Lilly's Investigational Medicine for Migraine Prevention Met Primary Endpoint in Phase 2b Study

June 18, 2015 11:39 am | News | Comments

Lilly will present data from this trial in a late-breaking session at the 57th Annual American Headache Society meeting on June 20 in Washington D.C. Read more...


Brain Receptor Found to Significantly Affect Cocaine Addiction

June 18, 2015 11:33 am | by University of Buffalo | News | Comments

Discovery of new neural pathway may lead to preventing relapses in addicts. Read more...


Reversing Depression

June 18, 2015 11:27 am | by MIT | News | Comments

The researchers believe this kind of targeted approach could have fewer side effects than most existing antidepressant drugs, which bathe the entire brain. Read more...


WHO Chief Reassures South Korea as MERS Deaths Reach 23

June 18, 2015 9:36 am | by Kim Tong-Hyung, Associated Press | News | Comments

The head of the World Health Organization on Thursday praised beleaguered South Korean officials and exhausted health workers, saying their efforts to contain a deadly MERS virus outbreak have put the country on good footing and lowered the public risk. Read more...


New Clue to How Cancer Causes Organ Failure

June 18, 2015 9:29 am | by Uppsala University | News | Comments

Cancer produces a variety of collateral effects in patients beyond the malignancy itself, including threats to distal organ functions. Read more...


Protein Discovery Fuels Re-Design of Mosquito-based Malaria Vaccine

June 18, 2015 9:26 am | by Monash University | News | Comments

A promising type of vaccine designed to eradicate malaria by blocking parasite transmission could be a step closer, as a result of experts uncovering new information about the targeted protein. Read more...


Pancreatic Cancer Treatment Pipeline Dominated by Early-Stage Development

June 18, 2015 9:12 am | by Joshua Libberton, Analyst, GBI Research | Articles | Comments

58 percent of drugs in the pancreatic cancer treatment pipeline are in the Discovery or Preclinical stages, 17 percent are in Phase 1 and 21 percent are in Phase 2, leaving just 4 percent of products in Phase 3 of development. Read more...


ICON Launches Patient Portal to Enhance Education Around Informed Consent

June 18, 2015 8:59 am | News | Comments

ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the Firecrest Patient Portal. This portal enables patients to view clinical trial information and is specifically designed to enhance the patients understanding of treatment before consenting to participate at an investigator site.  Read more...


Lilly, Dana-Farber Cancer Institute Announce Research Collaboration

June 18, 2015 8:59 am | News | Comments

Eli Lilly and Company and Dana-Farber Cancer Institute announced a multiyear collaboration to research new medicines under development to fight cancer. Read more...


New EU Post-Marketing Study Requirements for Vaccines: An Update

June 18, 2015 8:58 am | by Priscilla Velentgas, senior director of epidemiology, Quintiles Real-World and Late Phase Research; Ombretta Palucci, senior director, Real-World Evidence Strategy Unit, Quintiles Real-World and Late Phase Research | Articles | Comments

Under new draft guidance from the EMA, post-marketing studies of safety and effectiveness are required to be launched for seasonal influenza vaccines shortly after the beginning of the vaccination campaign each year. Based on this guidance, biopharma companies must take into account various operational, statistical and epidemiological elements in the planning of annual enhanced safety surveillance efforts. Read more...


DDT’s Health Effects Continue to Ripple, with New Breast Cancer Link

June 17, 2015 1:44 pm | by Seth Augenstein, Digital Reporter | News | Comments

DDT was a wonder pesticide, which turned the tide on everything from bed bugs to malaria-carrying mosquitoes during the 20th century. But even after its health and environmental effects were acknowledged and its agricultural use was banned in 1972, its toxic legacy continues, according to a new study. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.